Are insiders buying AKTS stock?

Yes — 6 distinct insiders have bought AKTS (Aktis Oncology, Inc.) on the open market, including 1 cluster buy where two or more insiders bought within a rolling window. The most recent qualifying activity was Jan 14, 2026.

How much AKTS stock have insiders bought?

Insiders have bought a combined $114.3M of AKTS across 9 open-market purchases, based on SEC Form 4 filings.

What is an insider cluster buy in AKTS?

A cluster buy is two or more distinct Aktis Oncology, Inc. insiders — officers, directors, or 10% owners — each buying AKTS on the open market within a rolling window. AKTS has 1 detected cluster buy to date.

Where does this AKTS insider trading data come from?

Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.

AKTS insider buying

1 cluster buy

Aktis Oncology, Inc. · Healthcare

When two or more insiders at Aktis Oncology, Inc. buy AKTS on the open market around the same time, that clustered conviction is one of the highest-signal patterns in SEC filing data. Below is every cluster we've detected in AKTS plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.

Clusters

Distinct insiders

Total bought

$114.3M

Market cap

$1.7B

Detected clusters

Jan 12 – Jan 12, 2026
Detected Jan 12, 2026
6 insiders
Total bought
$114.3M
Market cap
$1.7B

All notable open-market buys in AKTS

Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.

Date	Insider	Shares	Price	Value	Filing
Jan 12, 2026	NODELMAN OLEGcluster Director	2,077,779	$18.00	$37.4M	SEC ↗
Jan 12, 2026	GADICKE ANSBERTcluster 10% Owner	1,112,777	$18.00	$20.0M	SEC ↗
Jan 12, 2026	MPM ONCOLOGY INNOVATIONS FUND LPcluster 10% Owner	1,112,777	$18.00	$20.0M	SEC ↗
Jan 12, 2026	Kim Helen Susancluster Director, 10% Owner	812,455	$18.00	$14.6M	SEC ↗
Jan 12, 2026	VIDA VENTURES II-A, LLCcluster 10% Owner	812,455	$18.00	$14.6M	SEC ↗
Jan 12, 2026	Foley Toddcluster Director, 10% Owner	232,870	$18.00	$4.2M	SEC ↗
Jan 12, 2026	NODELMAN OLEGcluster Director	144,443	$18.00	$2.6M	SEC ↗
Jan 12, 2026	VIDA VENTURES II-A, LLCcluster 10% Owner	22,545	$18.00	$405.8K	SEC ↗
Jan 12, 2026	Kim Helen Susancluster Director, 10% Owner	22,545	$18.00	$405.8K	SEC ↗

More Healthcare stocks with insider cluster buys

All insider buying in Healthcare →

AKTS insider buying — FAQ

Are insiders buying AKTS stock?: Yes — 6 distinct insiders have bought AKTS (Aktis Oncology, Inc.) on the open market, including 1 cluster buy where two or more insiders bought within a rolling window. The most recent qualifying activity was Jan 14, 2026.
How much AKTS stock have insiders bought?: Insiders have bought a combined $114.3M of AKTS across 9 open-market purchases, based on SEC Form 4 filings.
What is an insider cluster buy in AKTS?: A cluster buy is two or more distinct Aktis Oncology, Inc. insiders — officers, directors, or 10% owners — each buying AKTS on the open market within a rolling window. AKTS has 1 detected cluster buy to date.
Where does this AKTS insider trading data come from?: Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.

How we track insider buying in AKTS

We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy AKTS within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?

This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding AKTS.